Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $1079.28
Oslo, Norway, May 12th, 2017: Photocure ASA (Photocure, PHO:OSE), today announced that a Phase 3 trial investigating Blue Light Flexible...
Oslo, 27 April 2017: Photocure ASA (OSE: PHO), held its annual general meeting on 27 April 2017 at 17:00 hours (CET). All proposals were resolved...
Data on US Registry Study for BLC(TM) with Cysview/Hexvix will also be Presented at AUA Oslo, Norway, April 26, 2017: Photocure ASA (Photocure...
ย Oslo, 24 April 2017: Photocure ASA (OSE: PHO). Bente-Lill Bjerkelund Romรธren has as chairperson of the board of directors of PHO received proxies...
ย Oslo, 24 April 2017: Photocure ASA (OSE: PHO). Hans Peter Bรธhn has received proxies to vote for 1,545,735 shares at the annual general meeting of...
On 6 April 2017 Kjetil Hestdal, President and CEO of Photocure ASA, purchased 5 000 Photocure shares at a price of NOK 28.00 each. Kjetil Hestdal...
Oslo, 6 April 2017: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2016. The annual...
Oslo, 6 April 2017: Photocure ASA (OSE: PHO), calls for the annual general meeting of PHO to be held at Hoffsveien 4, 1st floor, 0275 Oslo, Norway...
Following non-conclusive partnering discussions, the company will assess further strategic alternatives for Cevira and Visonac Company still to...
Oslo, Norway, 15 February 2017: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in cancer and...
Photocure will present its fourth quarter and full year 2016 report on Wednesday 15 February 2017 at Hotel Continental, Oslo, Norway. The...
Reference is made to the announcement on 24 November 2016 in respect of a capital increase of 12 481 new shares following exercise of employee...
Update on management shareholdings and exercise of employee share options in Photocure ASA ("the Company").ย Oslo, Norway, 24 November...
Oslo, Norway, 15 November 2016: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in cancer and...
Photocure will present its third quarter report on Tuesday 15 November 2016 at Hotel Continental, Oslo, Norway. The presentation will begin at...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.